Cargando…
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523330/ https://www.ncbi.nlm.nih.gov/pubmed/30987206 http://dx.doi.org/10.3390/pharmaceutics11040160 |
_version_ | 1783419309386629120 |
---|---|
author | Tyo, Kevin M. Minooei, Farnaz Curry, Keegan C. NeCamp, Sarah M. Graves, Danielle L. Fried, Joel R. Steinbach-Rankins, Jill M. |
author_facet | Tyo, Kevin M. Minooei, Farnaz Curry, Keegan C. NeCamp, Sarah M. Graves, Danielle L. Fried, Joel R. Steinbach-Rankins, Jill M. |
author_sort | Tyo, Kevin M. |
collection | PubMed |
description | Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architectures may offer new options to improve delivery to the female reproductive tract. In this review, we summarize the advancements of electrospun coaxial, multilayered, and nanoparticle-fiber architectures utilized in other applications and discuss how different material combinations within these architectures provide varied durations of release, here categorized as either transient (within 24 h), short-term (24 h to one week), or sustained (beyond one week). We seek to systematically relate material type and fiber architecture to active agent release kinetics. Last, we explore how lessons derived from these architectures may be applied to address the needs of future intravaginal delivery platforms for a given prophylactic or therapeutic application. The overall goal of this review is to provide a summary of different fiber architectures that have been useful for active agent delivery and to provide guidelines for the development of new formulations that exhibit release kinetics relevant to the time frames and the diversity of active agents needed in next-generation multipurpose applications. |
format | Online Article Text |
id | pubmed-6523330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65233302019-06-04 Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications Tyo, Kevin M. Minooei, Farnaz Curry, Keegan C. NeCamp, Sarah M. Graves, Danielle L. Fried, Joel R. Steinbach-Rankins, Jill M. Pharmaceutics Review Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architectures may offer new options to improve delivery to the female reproductive tract. In this review, we summarize the advancements of electrospun coaxial, multilayered, and nanoparticle-fiber architectures utilized in other applications and discuss how different material combinations within these architectures provide varied durations of release, here categorized as either transient (within 24 h), short-term (24 h to one week), or sustained (beyond one week). We seek to systematically relate material type and fiber architecture to active agent release kinetics. Last, we explore how lessons derived from these architectures may be applied to address the needs of future intravaginal delivery platforms for a given prophylactic or therapeutic application. The overall goal of this review is to provide a summary of different fiber architectures that have been useful for active agent delivery and to provide guidelines for the development of new formulations that exhibit release kinetics relevant to the time frames and the diversity of active agents needed in next-generation multipurpose applications. MDPI 2019-04-03 /pmc/articles/PMC6523330/ /pubmed/30987206 http://dx.doi.org/10.3390/pharmaceutics11040160 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tyo, Kevin M. Minooei, Farnaz Curry, Keegan C. NeCamp, Sarah M. Graves, Danielle L. Fried, Joel R. Steinbach-Rankins, Jill M. Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title_full | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title_fullStr | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title_full_unstemmed | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title_short | Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications |
title_sort | relating advanced electrospun fiber architectures to the temporal release of active agents to meet the needs of next-generation intravaginal delivery applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523330/ https://www.ncbi.nlm.nih.gov/pubmed/30987206 http://dx.doi.org/10.3390/pharmaceutics11040160 |
work_keys_str_mv | AT tyokevinm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT minooeifarnaz relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT currykeeganc relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT necampsarahm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT gravesdaniellel relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT friedjoelr relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications AT steinbachrankinsjillm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications |